Sublease AgreementSublease Agreement • January 10th, 2020 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJanuary 10th, 2020 Company Industry JurisdictionThis Commercial Sublease (this “Sublease”) is made effective as of March 12, 2019, by and between StartUptown dba Avenu (“Tenant”), and NeuBase Therapeutics Inc. (“Subtenant”). Tenant has previously entered into a lease agreement with Carnegie Mellon University (“Landlord”) dated March 12, 2019 (the “Prime Lease”), a copy of which is attached as an exhibit to this Sublease. Tenant now desires to sublet the leased property to Subtenant and Subtenant desires to sublet the leased property from Tenant. Therefore, the parties agree as follows:
AMENDMENT NO. 2 TO SUBLEASE AGREEMENTSublease Agreement • January 10th, 2020 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 10th, 2020 Company IndustryThis Amendment No. 2 to Sublease Agreement (this “Amendment”) is made and entered into this 29nd day of July 2019, with an effective date of August 1, 2019, by and between StartUptown dba Avenu (“Tenant”), and NeuBase Therapeutics Inc. (“Subtenant”). Tenant has previously amended its lease agreement with Carnegie Mellon University (“Landlord”) dated May 3, 2019 (the “Prime Lease”), a copy of which is attached as an exhibit to this Sublease.
AMENDMENT NO. 1 TO SUBLEASE AGREEMENTSublease Agreement • January 10th, 2020 • NeuBase Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 10th, 2020 Company IndustryThis Amendment No. 1 to Sublease Agreement (this “Amendment”) is made and entered into this 3rd day of May 2019, with an effective date of June 1, 2019, by and between StartUptown dba Avenu (“Tenant”), and NeuBase Therapeutics Inc. (“Subtenant”). Tenant has previously amended its lease agreement with Carnegie Mellon University (“Landlord”) dated May 3, 2019 (the “Prime Lease”), a copy of which is attached as an exhibit to this Sublease.